PortfoliosLab logoPortfoliosLab logo
LH vs. DGX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LH vs. DGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Laboratory Corporation of America Holdings (LH) and Quest Diagnostics Incorporated (DGX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LH achieves a 10.86% return, which is significantly lower than DGX's 21.05% return. Over the past 10 years, LH has underperformed DGX with an annualized return of 9.55%, while DGX has yielded a comparatively higher 11.74% annualized return.


LH

1D
-0.05%
1M
3.95%
6M
11.08%
YTD
10.86%
1Y
12.01%
3Y*
10.47%
5Y*
4.10%
10Y*
9.55%

DGX

1D
-0.04%
1M
2.53%
6M
19.39%
YTD
21.05%
1Y
25.52%
3Y*
16.12%
5Y*
11.16%
10Y*
11.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LH vs. DGX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LH
Laboratory Corporation of America Holdings
10.86%10.62%2.22%13.82%-24.41%54.37%20.32%33.88%-20.78%24.25%
DGX
Quest Diagnostics Incorporated
21.05%17.20%11.77%-10.05%-7.80%47.86%14.11%31.13%-13.84%9.16%

Correlation

The correlation between LH and DGX is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.77

Correlation (3Y)
Calculated over the trailing 3-year period

0.69

Correlation (5Y)
Calculated over the trailing 5-year period

0.70

Correlation (10Y)
Calculated over the trailing 10-year period

0.71

Correlation (All Time)
Calculated using the full available price history since Dec 26, 1996

0.55

Over the past year, LH and DGX have become more correlated (0.77) than their long-term average of 0.55, meaning their price movements have been converging.

Fundamentals

Market Cap

LH:

$22.69B

DGX:

$22.95B

EPS

LH:

$11.31

DGX:

$9.12

PE Ratio

LH:

24.47

DGX:

22.75

PS Ratio

LH:

1.63

DGX:

2.07

PB Ratio

LH:

2.63

DGX:

3.15

Total Revenue (TTM)

LH:

$14.14B

DGX:

$11.28B

Gross Profit (TTM)

LH:

$4.01B

DGX:

$3.75B

EBITDA (TTM)

LH:

$1.90B

DGX:

$1.98B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LH vs. DGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LH
LH Risk / Return Rank: 6060
Overall Rank
LH Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
LH Sortino Ratio Rank: 5757
Sortino Ratio Rank
LH Omega Ratio Rank: 5555
Omega Ratio Rank
LH Calmar Ratio Rank: 6363
Calmar Ratio Rank
LH Martin Ratio Rank: 6262
Martin Ratio Rank

DGX
DGX Risk / Return Rank: 7878
Overall Rank
DGX Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
DGX Sortino Ratio Rank: 7676
Sortino Ratio Rank
DGX Omega Ratio Rank: 7373
Omega Ratio Rank
DGX Calmar Ratio Rank: 8181
Calmar Ratio Rank
DGX Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LH vs. DGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LHDGXDifference
Sharpe ratioReturn per unit of total volatility

-0.58

Sortino ratioReturn per unit of downside risk

-0.92

Omega ratioGain probability vs. loss probability

1.11

1.21

-0.11

Calmar ratioReturn relative to maximum drawdown

0.79

2.22

-1.43

Martin ratioReturn relative to average drawdown

1.58

4.74

-3.16

LH vs. DGX - Sharpe Ratio Comparison

The current LH Sharpe Ratio is 0.52, which is lower than the DGX Sharpe Ratio of 1.10. The chart below compares the historical Sharpe Ratios of LH and DGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LH vs. DGX - Drawdown Comparison

The maximum LH drawdown since its inception was -96.15%, which is greater than DGX's maximum drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for LH and DGX.


Loading charts...

Drawdown Indicators


LHDGXDifference

Max Drawdown

Largest peak-to-trough decline

-96.15%

-49.46%

-46.69%

Max Drawdown (1Y)

Largest decline over 1 year

-15.22%

-11.55%

-3.67%

Max Drawdown (3Y)

Largest decline over 3 years

-17.36%

-16.57%

-0.79%

Max Drawdown (5Y)

Largest decline over 5 years

-34.61%

-28.62%

-5.99%

Max Drawdown (10Y)

Largest decline over 10 years

-46.58%

-36.60%

-9.98%

Current Drawdown

Current decline from peak

-4.14%

-3.62%

-0.52%

Average Drawdown

Average peak-to-trough decline

-29.55%

-11.87%

-17.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.61%

5.40%

+2.21%

Volatility

LH vs. DGX - Volatility Comparison

Laboratory Corporation of America Holdings (LH) has a higher volatility of 6.32% compared to Quest Diagnostics Incorporated (DGX) at 5.85%. This indicates that LH's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LHDGXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.32%

5.85%

+0.47%

Volatility (6M)

Calculated over the trailing 6-month period

16.17%

16.89%

-0.72%

Volatility (1Y)

Calculated over the trailing 1-year period

23.32%

23.33%

-0.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.48%

21.93%

+1.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.67%

23.80%

+2.87%

Dividends

LH vs. DGX - Dividend Comparison

LH's dividend yield for the trailing twelve months is around 1.04%, less than DGX's 1.60% yield.


PositionTTM20252024202320222021202020192018201720162015
DGX
Quest Diagnostics Incorporated
1.60%1.82%1.96%2.02%1.66%1.40%1.85%1.99%2.34%1.83%1.72%2.07%
LH
Laboratory Corporation of America Holdings
1.04%1.15%1.26%1.18%0.92%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

LH vs. DGX - Financials Comparison

This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.50B3.00B3.50B4.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
3.54B
2.90B
(LH) Total Revenue
(DGX) Total Revenue
Values in USD except per share items

LH vs. DGX - Profitability Comparison

The chart below illustrates the profitability comparison between Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

26.0%28.0%30.0%32.0%34.0%36.0%38.0%40.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
28.7%
32.5%
Portfolio components
LH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Laboratory Corporation of America Holdings reported a gross profit of 1.01B and revenue of 3.54B. Therefore, the gross margin over that period was 28.7%.

DGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Quest Diagnostics Incorporated reported a gross profit of 942.00M and revenue of 2.90B. Therefore, the gross margin over that period was 32.5%.

LH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Laboratory Corporation of America Holdings reported an operating income of 380.80M and revenue of 3.54B, resulting in an operating margin of 10.8%.

DGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Quest Diagnostics Incorporated reported an operating income of 399.00M and revenue of 2.90B, resulting in an operating margin of 13.8%.

LH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Laboratory Corporation of America Holdings reported a net income of 277.80M and revenue of 3.54B, resulting in a net margin of 7.9%.

DGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Quest Diagnostics Incorporated reported a net income of 252.00M and revenue of 2.90B, resulting in a net margin of 8.7%.


Frequently Asked Questions


LH and DGX have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LH has higher volatility (6.32%) compared to DGX (5.85%). In terms of maximum drawdown, LH dropped -96.15% vs DGX's -49.46%.

DGX currently has the higher Sharpe Ratio (1.10 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LH and DGX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer